1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,580 | 2,720 | 08:57 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Careium AB Announces Advance In Q2 Bottom Line | 1 | RTTNews | ||
| Fr | Careium steigert Umsatz im Q2 um 24 % dank Neukunden im Vereinigten Königreich und Norwegen | 1 | Investing.com Deutsch | ||
| Fr | Careium AB: Careium reports second quarter results 2026 | 73 | GlobeNewswire (Europe) | The second quarter in summaryNet sales increased by 24.3 percent to SEK 251.3 million (202.1)Organic growth 25.6 percent adjusted for currency effectsGrowth in all marketsGross margin amounted to 42.5... ► Artikel lesen | |
| Do | Careium AB: Careium repays hybrid loan to simplify capital structure | 125 | GlobeNewswire (Europe) | In connection with the listing of Careium AB (publ) ("Careium" or the "company") on Nasdaq First North Growth Market in 2021, the company raised a hybrid loan of SEK 50 million from its former owner... ► Artikel lesen | |
| 23.04. | Careium AB: Report from Annual General Meeting in Careium AB (publ) | 174 | GlobeNewswire (Europe) | At the Annual General Meeting in Careium AB (publ) ("Careium" or the "company") held on 23 April 2026, the following resolutions were passed. All resolutions were in accordance with the proposals, described... ► Artikel lesen | |
| 23.04. | Careium AB: Careium reports first quarter results 2026 | 343 | GlobeNewswire (Europe) | Summary first quarter 2026
Net sales increased by 5.9 percent to SEK 219.6 million (207.4)Net sales increased by 10.9 percent adjusted for currency effectsGrowth in all markets, adjusted for currency... ► Artikel lesen | |
| 27.03. | Careium AB: Tove Christiansson joins as CEO of Careium on June 1 | 200 | GlobeNewswire (Europe) | As earlier communicated, Tove Christiansson has been appointed CEO of Careium. Her first day in office will be June 1.
Tove holds a bachelor's degree from Lund University and brings over 20 years of... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 11.02. | Careium AB: Careium reports fourth quarter results 2025 | 362 | GlobeNewswire (Europe) | Summary fourth quarter 2025Net sales increased by 0.9 percent to SEK 230.9 million (228.9)Net sales increased by 6.3 percent adjusted for currency effectsNet sales increased by 13.1 percent adjusted... ► Artikel lesen | |
| 11.12.25 | Careium AB: Careium comments on full-year results | 272 | GlobeNewswire (Europe) | Careium's operations are developing well, however we are currently experiencing longer sales cycles than expected in UK and Germany for product sales. This impacts net sales, profitability and cashflow.... ► Artikel lesen | |
| 02.12.25 | Careium AB: Tove Christiansson appointed CEO of Careium | 300 | GlobeNewswire (Europe) | The Board of Directors of Careium has appointed Tove Christiansson as the CEO, effective Q2 2026. She succeeds interim CEO Peter Heuman, who will remain in his current role until the transition has... ► Artikel lesen | |
| 24.10.25 | Careium AB: Careium reports third quarter results 2025 | 225 | GlobeNewswire (Europe) | The third quarter in summaryNet sales increased by 6.0 percent to SEK 213.7 million (201.7)Net sales increased by 9.4 percent adjusted for currency effectsNet sales increased despite a negative impact... ► Artikel lesen | |
| 18.08.25 | Careium AB: President & CEO Christian Walén steps down from his position and Peter Heuman appointed as interim CEO | 439 | GlobeNewswire (Europe) | Careium's Board of Directors and Careium's President and CEO Christian Walén have mutually agreed that Christian Walén steps down from the role of President and CEO, effective immediately.
"The Board... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 41,020 | 0,00 % | DAX-Rekordjagd beendet - DHL Group, Fresenius, Rheinmetall, SAP und Talanx im Check | Die Rekordjagd im DAX ist zur Wochenmitte erst einmal beendet. Gewinnmitnahmen nach dem jüngsten Hochlauf, erneute Schwäche bei KI- und Halbleiterwerten sowie schwache Vorgaben aus Asien bremsen die... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,290 | 0,00 % | Siemens Healthineers: Berenberg wird vorsichtiger | Die Analysten der Privatbank Berenberg haben ihr Kursziel für Siemens Healthineers von 54 auf 39 € gesenkt und die Einstufung von "Buy" auf "Hold" reduziert. Die Begründung: Bei den Faktoren, die dem... ► Artikel lesen | |
| THERMO FISHER | 466,10 | -0,41 % | Persistence Market Research Pvt. Ltd.: Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG | LONDON, July 8, 2026 /PRNewswire/ -- Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 68,48 | +0,29 % | Eurofins Scientific SE: Weekly Report on Share Repurchases From 06th July to 10th July 2026 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Weekly report on share repurchases from 06th July to 10th July 2026 Name of the Issuer... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| DAVITA | 202,70 | -0,30 % | Ausnahmen Im KI-Rausch: 15 S&P-Aktien haben sich seit Jahresanfang verdoppelt - zwei davon ohne KI-Hype | © Foto: KI-generiert mit DALL-E15 Aktien aus dem S&P 500 haben sich 2026 bereits verdoppelt. 13 stammen aus dem KI-Umfeld. Nur Moderna und DaVita tanzen aus der Reihe. Können sie noch überraschen? Der... ► Artikel lesen | |
| DENTSPLY SIRONA | 11,195 | +0,63 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Appoints John Fortson as Chief Financial Officer | CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products... ► Artikel lesen | |
| SMITH & NEPHEW | 13,900 | +5,30 % | Smith & Nephew Plc: New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions | Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication of new consensus-based guidance - developed independently by expert clinicians for the use of... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,960 | -0,26 % | Dividendenbekanntmachungen (04.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASPIAL LIFESTYLE LIMITED SG2E90982678 0,008 SGD 0,0053 EUR AUTOLIV INC US0528001094 0,87 USD 0,7491 EUR AVERY DENNISON CORP US0536111091 0... ► Artikel lesen | |
| DIASORIN | 69,44 | 0,00 % | DiaSorin speculated to have rebuffed takeover offer from US suitor - report | ||
| FULGENT GENETICS | 17,800 | 0,00 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| IMPLANTICA | 5,830 | +0,52 % | Implantica AG: Bulletin from the Annual General Meeting of Implantica AG | Today, June 10, 2026, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,510 | -6,48 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor | SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| OMNICELL | 40,200 | -0,50 % | KeyBanc reiterates Omnicell stock rating on Titan XT launch | ||
| LEVITEE LABS | 0,010 | -100,00 % | CSE Bulletin: Delist - Levitee Labs Inc. (LVT) | Toronto, Ontario--(Newsfile Corp. - Le 26 janvier/January 2026) - The common shares of Levitee Labs Inc. will be delisted from the CSE at market close today, January 26, 2026. Levitee Labs... ► Artikel lesen |
CAREIUM AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,610 Euro und damit +1,16 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.